close

Mergers and Acquisitions

1 2 3 4 5 28
Number of results: 557
Date Acquired company Acquiring company Amount Related
2016-09-20 Tobira Therapeutics (USA - CA) Allergan (Ireland) up to $1.695 billion

Hepatic diseases

Liver diseases

2016-09-20 Akarna Therapeutics (UK - USA - CA) Allergan (Ireland) up-front payment of $50 million and potential clinical, regulatory and commercial milestone payments

Hepatic diseases

Liver diseases

2016-09-14 Vitae Pharmaceuticals (USA - PA) Allergan (Ireland) $639 million

Autoimmune diseases

Dermatological diseases

2016-09-13 InterHealth Nutraceuticals (USA - CA) Lonza (Switzerland) up to $ 300 million

Nutrition

Nutraceuticals

2016-09-12 Raptor Pharmaceutical (USA - CA) Horizon Pharma (Ireland) $800 million (€711.6 million)

Rare diseases

2016-09-12 GSK's anaesthesia portfiolo and thrombosis business Aspen Global Incorporated (South Africa) £180 million plus milestones of up to £100 million
2016-09-06 RetroSense Therapeutics (USA - MI) Allergan (Ireland) $60 million and undisclosed milestone payments

Ophtalmological diseases

Gene therapy

2016-09-01 Cynapsus Therapeutics (Canada) Sumitomo Dainippon Pharma (Japan) Sunovion (USA) $ 624 million (€ 559 million)

CNS diseases

Neurological diseases

2016-08-26 Transition Therapeutics (Canada) Opko Health (USA - FL) $60 million

CNS diseases

Metabolic diseases

Hormonal diseases

2016-08-24 Astra Zeneca's late-stage small molecule antibiotics business Pfizer (USA - NY) up to $1.3 billion

Infectious diseases

2016-08-15 stake in Isomerase Therapeutics (UK) Neurovive Pharmaceutical (Sweden) £ 0.55 million (€ 0.72 million)
2016-08-12 Flamel Technologies (France) Avadel Pharmaceuticals (Ireland)

Specialty pharma

2016-08-11 ForSight VISION5 (USA - CA) Allergan (Ireland) $95 million upfront payment and launch milestone payment

Ophtalmological diseases

2016-08-05 Meda (Sweden) Mylan (USA - PA) $ 9.9 billion

OTC

generics

2016-08-02 Allergan's generic business (Ireland) Teva Pharmaceutical Industries (Israel) $40.5 billion

Generic drugs

2016-08-01 Bamboo Therapeutics (USA - NC) Pfizer (USA - NY) up to $ 645 million

Rare diseases

Neuromuscular diseases

Gene therapy

2016-07-27 FirstString Research (USA - SC) Relief Therapeutics (Switzerland) undisclosed
2016-07-26 BIND Therapeutics (USA - MA) Pfizer (USA - NY) $40 million

Cancer - Oncology

2016-07-22 Synta Pharmaceuticals (USA - MA) Madrigal Pharmaceuticals (USA - PA)

Cardiovascular diseases

Metabolic diseases

Liver diseases

2016-07-14 RedoxTherapies (USA - MA) Juno Therapeutics (USA - CA) $10 million in cash and milestones

Cancer - Oncology